<DOC>
	<DOCNO>NCT02378792</DOCNO>
	<brief_summary>Evaluate long-term clinical effectiveness safety PINS vagus nerve stimulator patient refractory epilepsy .</brief_summary>
	<brief_title>Clinical Trial Vagus Nerve Stimulation Treatment Refractory Epilepsy</brief_title>
	<detailed_description />
	<mesh_term>Epilepsy</mesh_term>
	<mesh_term>Drug Resistant Epilepsy</mesh_term>
	<criteria>1 . Age 660 . 2 . Having try least two appropriate antiepileptic drug ( AEDs ) test tolerance blood level upper end target range least 2 tolerate normal dose . 3 . At least 1 seizure per month . 4 . In good health except epilepsy . 5 . With normal MMSE score 6 . Patients ( ) familyscould understand method sign inform consent 7）Patients good compliance could complete postoperative followup . 1 . Results MRI remind epilepsy cause intracranial spaceoccupying lesion . 2 . The vagus nerve lesion damage 3 . Tumor , cardiopulmonary anomaly , progressive neurological disease , asthma，mental disease，pepticulcer，diabetes Type 1，bad health etc , surgical contraindication 4 . Alcohol addiction , smoking , sleeprelated breathing disorder</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>PINS VNS Refractory Epilepsy</keyword>
</DOC>